Literature DB >> 1092909

Pathophysiologic responses of the subhuman primate in experimental septic shock.

J J Coalson, L B Hinshaw, C A Guenter, E L Berrell, L J Greenfield.   

Abstract

The grave clinical aspects of septic shock have stimulated the search for an experimental animal model which more closely relates to human pathophysiology. This study of the cardiovascular-pulmonary-morphologic responses of the baboon to slow infusions of live Escherichia coli organisms was designed to approximate more closely the human clinical entity. Anesthetized young adult baboons received 3-hour intravenous infusions of organisms at an average dosage of 8 times 10-9 organisms per kg. body weight. Responses of animals were followed during a period of 6 hours in the anesthetized state. There was progressive systemic hypotension and steadily decreasing cardiac output. Total peripheral resistance was uniformly depressed during the infusion, but was variable during the post-infusion survival period. Increases in heart rate, alveolar-arterial oxygen tension gradient, and oxygen uptake were uniformly present. These alterations bear close resemblance to those seen in other subhuman primates administered short term doses of live organisms. There were extensive morphologic changes in pulmonary, cardiac, and renal beds. Glomeruli contained multiple fibrin thrombi and disrupted platelets, and the glomerular capillary endothelium was focally edematous and disrupted. The myocardium exhibited capillary endothelial edema and fluid accumulation in interfiber and intrafiber spaces. There were sequestration, degranulation, and fragmentation of polymorphonuclear leukocytes and platelets, and characteristic endothelial lesions within the pulmonary vascular bed. Findings demonstrate both cardiovascular-pulmonary dysfunction and renal, cardiac, and pulmonary morphologic lesions. The baboon shock model appears to be well suited for studies of experimental septic shock and bears close resemblance to the human clinical entity.

Entities:  

Mesh:

Year:  1975        PMID: 1092909

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis.

Authors:  A R Webb; R F Moss; D Tighe; M G Mythen; N al-Saady; A E Joseph; E D Bennett
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Lung pathology in septic shock.

Authors:  B Corrin
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

3.  Quercetin exerts cardiovascular protective effects in LPS-induced dysfunction in vivo by regulating inflammatory cytokine expression, NF-κB phosphorylation, and caspase activity.

Authors:  Xiqing Wei; Xiangli Meng; Yuxiang Yuan; Fengjuan Shen; Chengqiu Li; Jun Yang
Journal:  Mol Cell Biochem       Date:  2018-01-10       Impact factor: 3.396

Review 4.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

5.  [Septic shock and multiple organ failure in surgical intensive care. An animal experiment model on the analysis of pulmonary and intestinal dysfunction].

Authors:  C Töns; B Klosterhalfen; U Klinge; C J Kirkpatrick; C Mittermayer; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1993

Review 6.  [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].

Authors:  L Martin; M Derwall; C Thiemermann; T Schürholz
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

Review 7.  Sepsis-induced myocardial dysfunction: pathophysiology and management.

Authors:  Yasuyuki Kakihana; Takashi Ito; Mayumi Nakahara; Keiji Yamaguchi; Tomotsugu Yasuda
Journal:  J Intensive Care       Date:  2016-03-23

8.  PINK1 contained in huMSC-derived exosomes prevents cardiomyocyte mitochondrial calcium overload in sepsis via recovery of mitochondrial Ca2+ efflux.

Authors:  Qin Zhou; Min Xie; Jing Zhu; Qin Yi; Bin Tan; Yasha Li; Liang Ye; Xinyuan Zhang; Ying Zhang; Jie Tian; Hao Xu
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.